PRRT2 and glioblastoma: Taking these facts into consideration, it seems reasonable to hypothesize that regulating the activity of specific PKC isozymes (i.e., activating the novel PKC isozymes and inhibiting the classical variants) may result in an interesting strategy to halt GBM growth and survival, migration and invasion.